A tumor is a solid mass that forms when abnormal cells group together. Tumors happen when something goes wrong with the genes that manage cell growth, allowing cells to grow and divide out of control.
Tumors can form anywhere in the body, including the brain and spinal cord—the bundle of nerves and nerve fibers that sends and receives signals from the brain. The brain and spinal cord make up the central nervous system (CNS).
Some tumors don’t cause any symptoms. Others can kill or damage healthy cells, press on sensitive body tissue, or block the flow of blood, fluid, or signals to and from the brain.
There are treatments available to keep tumors from getting worse—especially when detected early.
Tumors don’t always mean cancer. They can either be:
CNS tumors are known as primary tumors if they first form in the brain or spinal cord. They’re called secondary (or metastatic) tumors if they break off from a tumor somewhere else in the body and travel to the brain or spinal cord. Secondary tumors are more common than primary CNS tumors and happen more often in adults than in children.
There are more than 120 types of brain and spinal cord tumors. Some of these tumors are only benign or malignant, but others may be both, depending on how much they’ve progressed. The National Cancer Institute (NCI) has more information on rare brain and spine tumors.
The following CNS tumors are grouped based on whether they are more likely to be benign or malignant:
Gliomas are the most common type of brain tumor. They grow from several types of glial cells, which support brain cell function. Astrocytomas are a type of glioma that forms in star-shaped glial cells called astrocytes. Other types of gliomas include:
Not all gliomas progress at the same rate, and how much they affect the person varies. Prognosis for a glioma depends on how serious the tumor is, as well as factors like a person’s age and other medical history.
CNS tumors cause many different symptoms, which can make catching them difficult. Symptoms depend on location, size, growth rate, and tumor type.
Headaches are the most common brain tumor symptom, and back pain is a common early symptom of spinal cord tumors.
Damage to specific areas of the brain and spinal cord lead to specific symptoms. For example, a tumor in the motor area (which coordinates voluntary movement) may cause muscle weakness.
A brain tumor can cause a variety of symptoms, including:
Other possible brain tumor symptoms in adults are movement and balance problems, including:
In infants, the most obvious sign of a brain tumor is a rapidly widening head or swelling around the soft spot at the top of the head.
Common symptoms of a spinal cord tumor include:
Anyone can develop a primary brain or spinal cord tumor, but the overall risk is very small. Among people who do develop CNS tumors, they’re most common in older adults.
Although brain tumors are uncommon in children, they tend to happen most often in children under age 9. Brain tumors are the leading cause of cancer deaths in children.
Researchers are still figuring out why CNS tumors develop, especially primary ones. Possible causes include:
Some conditions that cause tumors tend to run in families—and gene mutations or genetic diseases can lead to primary CNS tumors. They can include:
Other risk factors for developing a primary CNS tumor include race (White men, for instance, are more likely to develop a CNS tumor) and occupation. Specifically, workers in jobs that require repeated contact with ionizing radiation or certain chemicals—including materials used in building supplies, plastics, textiles—have a greater chance of developing a brain tumor.
To diagnose a CNS tumor, a doctor will review the person’s medical and family history and do physical and neurological exams. At some point, the doctor will likely refer a patient to a specialist—such as a neurologist, oncologist, or neuro-oncologist.
Getting specialized medical advice on brain and spinal cord tumors is important because diagnosing the type of brain or spinal cord tumor is often difficult. Some tumor types are rare and not well understood. It can help to get a second opinion from a comprehensive cancer center or neuro-oncologist with experience treating the specific tumor type.
To diagnose a brain or spinal cord tumor, a doctor may order diagnostic imaging procedures, which may include:
Laboratory and other tests can also help diagnose CNS tumors, including:
Find out more about neurological diagnostic tests and procedures.
Malignant tumors require some form of treatment, while some small benign tumors may need only monitoring. Tumor treatment is different and unique for each person. A specialized team of doctors advises and assists people throughout brain and spinal cord tumor treatment. The treatment team may include a:
The healthcare team will recommend a treatment plan based on the tumor’s location, type, size, and aggressiveness. They will also consider the person’s medical history, age, general health, and support system to select the best treatment plan.
Initial treatment for a CNS tumor may involve a variety of medicines to treat or ease symptoms, including:
Medicines to treat tumors directly can include targeted therapy, which works on specific genes and proteins involved in tumor cell growth. Some examples of targeted therapies are inhibitors for BRAF and IDH mutations, which can cause malignant tumors.
Treatment for CNS tumors can also include a combination of any of the following treatments:
Neurosurgery (surgery on the CNS) is usually the first treatment doctors will consider to treat brain and spinal cord tumors. Sometimes, surgery can completely remove a tumor.
Some tumors are located deep within the brain, near vital structures (such as the brain stem), or don’t have well-defined edges. In these cases, surgery may be too risky, but a biopsy can help doctors understand a tumor and its needed treatment better.
During neurosurgery or biopsies, neurosurgeons will use different tools to reduce the risk of damage to the tissues surrounding the tumor. These include imaging to guide the surgeon during surgery and direct electrical stimulation of the brain to help the surgeon find the parts of the brain that control different things like movement or vision. Sometimes, patients may be awake during neurosurgery so surgeons can check their movement and speech during the procedure.
For malignant tumors, find more information on surgery to treat cancer.
Alternative and complementary therapies may help people with a tumor better cope with their diagnosis, treatment, or symptoms. Some of these therapies, however, may be harmful if people use them during or after standard treatments. The healthcare team can help patients safely plan for alternative and complementary therapies.
Common examples include:
NINDS, a component of the National Institutes of Health (NIH), is the leading federal funder of research on the brain and nervous system, including research on brain and spinal cord tumors. NINDS supports new and innovative research to better understand, diagnose, and treat CNS tumors. NINDS-supported research projects cover a wide range of topics on these tumors. NIH supports much of its CNS tumor research through the collaborative efforts of NINDS and the National Cancer Institute (NCI).
Several of today’s CNS treatments were experimental therapies only a decade ago. Scientists continue to investigate ways to better understand, diagnose, and treat CNS tumors. Their research that looks at genetic risk factors, environmental causes, and molecular mechanisms of tumors could lead to breakthrough treatments.
Jointly, the Surgical Neurology Branch of NINDS and the NCI Neuro-Oncology Branch coordinate clinical care and research to develop and test the effectiveness/safety of new therapies for people with CNS tumors. These experimental treatment options may include new medicines, combination therapy, gene therapy, advanced imaging and artificial intelligence, biologic “immuno-agents”, surgery, and radiation.
The immune system attacks foreign substances in the body, but because the body doesn’t always identify cancer cells as foreign, in many different brain tumors they don’t cause much of an immune response. Researchers are testing different biological therapies and immunotherapies to provoke a strong immune response to tumor cells, including:
Researchers are exploring new targeted therapy and drug delivery approaches. NCI and NINDS are funding research to understand which types of cancer cells in the brain are more likely to aggressively invade surrounding healthy tissue. The Food and Drug Administration has approved targeted therapies for BRAF and IDH mutations, which can cause malignant tumor growth. Researchers are continuing to advance these treatments.
Scientists are testing different therapies to target cells that turn cancerous, including:
Biomarkers are molecules or other substances in the blood or tissue that can be used to diagnose or monitor a disorder. Identifying CNS tumor biomarkers can help scientists understand the risk of developing tumors from environmental toxins and other causes. This research may also lead to the development of new treatments. NIH scientists have found some CNS tumor biomarkers, such as the epithelial growth factor receptor (EGFR) gene, and have identified glial fibrillary acid protein (GFAP) as another possible biomarker. Identifying biomarkers may lead to better diagnosis, monitoring, and treatment of tumors.
Researchers are finding new ways to combine treatments—like radiation therapy and chemotherapy—with other therapies. This can possibly make these treatments less toxic and more effective.
Surgery research helps scientists understand how to combine surgery with other treatments and improve the quality of life and survival after surgery on CNS tumors. NINDS-supported researchers are testing out ways to improve the surgery process—such as using fluorescence and other new imaging techniques to guide surgeons in removing tumors.
Clinical trials increase our understanding of CNS tumors with the goal of improving how doctors treat them. Consider participating in a clinical trial so clinicians and scientists can learn more about brain and spinal tumors. Clinical research with human participants helps researchers learn more about a disorder and perhaps find better ways to detect, treat, or prevent disease safely.
All types of participants are needed—those who are healthy or may have an illness or disease—of all different ages, sexes, races, and ethnicities. This helps make sure that study results apply to as many people as possible, and that treatments will be safe and effective for everyone who will use them.
For information about participating in clinical research, visit NIH Clinical Research Trials and You. Learn about clinical trials currently looking for people with CNS tumors at Clinicaltrials.gov, a searchable database of current and past clinical studies and research results.
Curafile is the biggest Healthcare Curated Network Globally that serves citizens, service providers in one place.